|Articles|May 1, 2012
- BioPharm International-05-01-2013
- Volume 26
- Issue 5
BioPharm International, May 2012 Issue (PDF)
Monoclonal Antibodies : Developing an Alternative Polishing Step
Advertisement
Articles in this issue
over 12 years ago
Regulatory Convergence Sought for Global Pharma Marketover 12 years ago
Measuring Protein Mobility with Electrophoretic Light Scatteringover 12 years ago
Data and Systems Managementover 12 years ago
Report from Brazilover 12 years ago
The Future of Valves and Diaphragms Supplyover 12 years ago
Extractables and Leachables: Best Practices to Ensure Patient Safetyover 12 years ago
Facility Trends: Modularization and Single UseNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
2
How Biopharma Navigates the 2026 Economic Shift
3
EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy
4
Beyond Transactional: Collaborative Partnerships for Rapid, Flexible Biologics Development
5
